Tdap in pregnancy timing safety and how it protects your newborn from whooping cough

Tdap in Pregnancy: Timing, Safety, and How It Protects Your Newborn From Whooping Cough

The CDC and ACOG recommend getting a Tdap vaccine during every pregnancy, ideally at 27–36 weeks, to pass protective antibodies to your newborn and lower the risk of whooping cough in the first 2 months by about 78% and hospitalizations by about 91%. Extensive CDC monitoring and large studies show Tdap is safe in pregnancy and while breastfeeding.

Whooping cough (pertussis) can be life-threatening for young infants who are too young to start their own DTaP vaccine series. Vaccinating during pregnancy safely boosts maternal antibodies that cross the placenta so babies have protection from birth until they can be vaccinated themselves.

Key Takeaways

  • Get Tdap during every pregnancy between 27–36 weeks; earlier in that window is preferred to maximize antibody transfer.
  • Maternal Tdap reduces pertussis in infants under 2 months by about 78% and hospitalizations by about 91%.
  • Tdap is considered safe in pregnancy and breastfeeding; large studies show no increased risk of adverse birth outcomes.
  • You still need Tdap in each pregnancy even if you had Tdap recently or had whooping cough before.
  • If you miss the prenatal window, get Tdap postpartum; it protects you but does not pass antibodies to your newborn.
  • Your baby’s DTaP schedule does not change after maternal Tdap; start at 2, 4, and 6 months as usual.

What is pertussis (whooping cough), and why are newborns at highest risk?

Pertussis is a highly contagious respiratory infection that can cause severe coughing, pneumonia, and apnea in infants, and most deaths occur in babies too young for vaccination. About half of infants younger than 1 year who get pertussis require hospitalization, making prevention during pregnancy critical.

Pertussis spreads through respiratory droplets and can start like a common cold before progressing to fits of violent coughing. Newborns are especially vulnerable because their immune systems are immature and they cannot begin the DTaP series until 2 months of age. Serious complications in infants include apnea, pneumonia, seizures, and, rarely, death.

  • Infants under 2 months are not yet eligible for their first DTaP dose.
  • Household adults and siblings are common sources of infant exposure.
  • Early protection depends on antibodies passed from the mother during pregnancy.

When should you get the Tdap vaccine during pregnancy, and why does timing matter (27–36 weeks)?

Get one dose of Tdap during every pregnancy, ideally between 27–36 weeks’ gestation, to maximize the transfer of protective antibodies to your baby. CDC and ACOG advise giving Tdap early in this 27–36 week window so high antibody levels are present and can cross the placenta before birth.

The placenta transfers most maternal IgG antibodies in the third trimester, so vaccinating at 27–36 weeks produces the best antibody levels in the newborn at delivery. If Tdap is needed earlier in pregnancy for wound management or other reasons, it can be given; only one Tdap dose is recommended per pregnancy.

Is Tdap safe in pregnancy and breastfeeding? What does the evidence show about mom and baby?

Yes. CDC surveillance and large cohort studies show Tdap is safe in pregnancy, with no increased risk of adverse birth outcomes such as preterm birth, low birth weight, or stillbirth. Tdap is also considered safe during breastfeeding.

A large U.S. cohort study found maternal Tdap was not associated with increased risks of preterm delivery, low birth weight, or hypertensive disorders of pregnancy. In 2022, the FDA approved Boostrix for immunization during pregnancy to help prevent pertussis in infants younger than 2 months, reflecting supportive safety and effectiveness data. CDC and ACOG endorse Tdap in each pregnancy as standard care.

  • Breastfeeding is not a contraindication to Tdap; vaccination is compatible with lactation.
  • Tdap can be given at the same visit as influenza or COVID-19 vaccines at different injection sites.
  • Either Tdap product used in the United States may be given during pregnancy per national recommendations.

Do you still need Tdap if you had it recently or previously had whooping cough?

Yes. You should receive Tdap during every pregnancy regardless of when you last received Tdap or whether you had pertussis before. Protection from both vaccination and natural infection wanes over time, and a fresh dose in each pregnancy is needed to provide your newborn with passive antibodies.

Even if your last pregnancy or a prior booster was within a couple of years, repeating Tdap in the current pregnancy is recommended to rebuild maternal antibody levels for efficient placental transfer. Prior infection does not reliably confer durable protection, and it does not ensure high antibody levels at delivery.

What if you miss the window—should you get Tdap after delivery, and does cocooning work?

If you miss Tdap during pregnancy, get it as soon as possible after delivery if you’ve never had a Tdap before; this protects you but does not pass antibodies to your newborn. Cocooning—vaccinating close contacts—is helpful but not sufficient by itself, and CDC emphasizes maternal vaccination during pregnancy as the best way to protect infants.

When mom gets TdapPassive antibodies to baby at birthEffect on infant pertussis (first 2 months)Effect on infant hospitalizationWho is directly protected
During pregnancy (27–36 weeks)Yes (high)About 78% fewer cases in infants <2 monthsAbout 91% fewer hospitalizationsMother and baby
After delivery (postpartum)NoNo direct reduction from maternal antibodiesNo direct reduction from maternal antibodiesMother only
  • If unvaccinated with Tdap, receive it before hospital discharge after delivery.
  • Ask all household members and caregivers who have never had Tdap to get a dose at least 2 weeks before close contact with your baby.
  • Continue general measures: hand hygiene, staying home when sick, and avoiding close contact with anyone who has a cough.

Does maternal Tdap affect your baby’s DTaP schedule or response to vaccines?

No. Maternal Tdap does not change your baby’s DTaP schedule; infants should receive DTaP at 2, 4, and 6 months, then 15–18 months, and 4–6 years. Some blunting of early antibody responses can occur, but infants still achieve protection with the routine series, and the benefits of maternal vaccination outweigh this effect.

Your pediatrician will follow the standard CDC schedule regardless of maternal vaccination. The goal of maternal Tdap is to bridge the gap in the first months before your baby’s own vaccines can take effect.

What side effects are common, and who should talk to their clinician before getting Tdap?

Most people have mild, short‑lived side effects such as arm soreness, redness, swelling, tiredness, or low‑grade fever. Serious reactions are rare.

  • Common: pain, redness, or swelling at the injection site; mild fever; headache; fatigue; body aches.
  • Seek care urgently for signs of a severe allergic reaction (e.g., hives, trouble breathing, swelling of face or throat).
  • Talk with your clinician if you ever had a severe allergic reaction to a vaccine component, encephalopathy within 7 days of a prior pertussis vaccine, Guillain‑Barré syndrome within 6 weeks of a tetanus‑containing vaccine, or a prior Arthus‑type reaction.

It is acceptable to receive Tdap on the same day as influenza or COVID‑19 vaccines at different injection sites. If you have a moderate or severe acute illness, clinicians may recommend deferring vaccination until you recover.

How can partners and caregivers help protect your newborn from pertussis?

Ensure all close contacts are up to date: anyone who has never had Tdap should get a dose, ideally at least 2 weeks before they spend time with your baby. People who already received one Tdap do not need another dose for cocooning, but they should stay current with 10‑year Td/Tdap boosters.

  • Ask partners, grandparents, and babysitters if they have ever had a Tdap; if not, they should get one before meeting the baby.
  • Practice everyday prevention: wash hands, cover coughs, and avoid visiting when ill.
  • Follow the infant’s routine vaccine schedule on time to build direct protection.

Frequently Asked Questions

Can I get Tdap earlier than 27 weeks if there’s a reason?

Yes. If Tdap is needed earlier in pregnancy (for example, for wound management or during an outbreak), it can be given. Only one Tdap dose is recommended per pregnancy, so it should not be repeated at 27–36 weeks if it was already given earlier in the same pregnancy.

Is it safe to get Tdap with my flu or COVID‑19 vaccine on the same day?

Yes. CDC allows Tdap to be given at the same visit as influenza and COVID‑19 vaccines using different injection sites. Coadministration helps you stay on schedule without additional visits.

Which Tdap vaccine is used in pregnancy?

CDC allows either U.S. Tdap product to be used during pregnancy. In 2022, FDA approved Boostrix specifically for immunization during pregnancy to help prevent pertussis in infants younger than 2 months, but either product may be administered per national recommendations.

I had Tdap last year after delivery. Do I still need it in this pregnancy?

Yes. A dose of Tdap is recommended during every pregnancy, regardless of when you last received Tdap. Re‑vaccinating boosts antibodies so they can be passed to your newborn.

Does breastfeeding protect my baby from whooping cough?

Breastfeeding has many benefits and may provide some antibodies in milk, but it does not replace maternal Tdap during pregnancy for preventing pertussis in the first weeks of life. Vaccination in pregnancy is the most effective way to provide passive, systemic protection at birth.

If I miss Tdap during pregnancy, when should I get it after delivery?

If you have never had a Tdap, get it as soon as possible postpartum, ideally before hospital discharge. This protects you and reduces the chance you could spread pertussis to your baby, though it does not provide passive antibodies to the infant.

Sources

  1. CDC — Tdap Vaccination for Pregnant Women
  2. American College of Obstetricians and Gynecologists (ACOG) — Update on Immunization and Pregnancy: Tetanus, Diphtheria, and Pertussis Vaccination
  3. FDA — FDA approves Boostrix for immunization during pregnancy to prevent pertussis in infants younger than 2 months
  4. CDC — Pertussis (Whooping Cough): About
  5. CDC — Child and Adolescent Immunization Schedule
  6. CDC — General Best Practice Guidelines for Immunization: Contraindications and Precautions
  7. JAMA — Maternal Tdap vaccination and risk of adverse birth outcomes
  8. CDC — Vaccines and Pregnancy: Guidelines for Healthcare Professionals

The views, statements, and pricing expressed are deemed reliable as of the published date. Articles may not reflect current pricing, offerings, or recent innovations.